138 related articles for article (PubMed ID: 5631729)
1. [Iron storage disease].
Heilmeyer L
Munch Med Wochenschr; 1967 Mar; 109(13):677-84. PubMed ID: 5631729
[No Abstract] [Full Text] [Related]
2. [Disorders of iron metabolism in liver patients].
Stromeyer G
Internist (Berl); 1966 Jan; 7(1):33-42. PubMed ID: 4861683
[No Abstract] [Full Text] [Related]
3. [Diseases caused by iron metabolism disorders and their therapy].
Stacher A
Wien Z Inn Med; 1969; 50(3):89-105. PubMed ID: 4903041
[No Abstract] [Full Text] [Related]
4. [Hemochromatosis (apropos of 100 cases)].
Darnis F
Ann Biol Clin (Paris); 1972; 30(4):349-78. PubMed ID: 5082971
[No Abstract] [Full Text] [Related]
5. Desferal therapy in iron storage disease.
Thompson RB; Owen DM; Bell WN
Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
[No Abstract] [Full Text] [Related]
6. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
Giardini C; La Nasa G; Contu L; Galimberti M; Polchi P; Angelucci E; Baronciani D; Barbanti I; Muretto P; Lucarelli G
Bone Marrow Transplant; 1993; 12 Suppl 1():108-10. PubMed ID: 8374548
[No Abstract] [Full Text] [Related]
7. [First results of a new iron chelating agent in the treatment of post-transfusional hemochromatosis].
Giraud P; Orsini A; Giraud F; Pinsard N
Arch Fr Pediatr; 1965 Apr; 22(4):463-8. PubMed ID: 5826583
[No Abstract] [Full Text] [Related]
8. [Hemochromatosis].
Simon M; Hespel JP; Brissot P; Fauchet R; Edan G; Le Reun M; Le Mignon L; Genetet B; Bourel M
Ann Med Interne (Paris); 1981; 132(6):413-33. PubMed ID: 7032384
[No Abstract] [Full Text] [Related]
9. Treatment of iron storage disorders.
Halliday JW; Bassett ML
Drugs; 1980 Sep; 20(3):207-15. PubMed ID: 7428669
[No Abstract] [Full Text] [Related]
10. Liver iron overload and liver fibrosis in thalassemia.
Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P
Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556
[No Abstract] [Full Text] [Related]
11. [Physiopathology and classification of hemochromatosis].
Bourel M; Simon M; de Nercy YH; Brissot P; Hespel JP
Rev Prat; 1977 Feb; 27(7):339-50. PubMed ID: 322245
[No Abstract] [Full Text] [Related]
12. [Present aspects of the treatment of hemochromatosis (apropos of 100 observations)].
Darnis F; Mossé A; Breauté C; Delorme ML
Ann Med Interne (Paris); 1971 Dec; 122(12):1193-210. PubMed ID: 5151624
[No Abstract] [Full Text] [Related]
13. Improvement in Left Ventricular Function Despite No Change in T2* with Iron Chelation in Secondary Hemochromatosis.
Nijjar PS; Vongooru H; Tamene A; Valeti U; Masri C
Minn Med; 2015 Jul; 98(7):47. PubMed ID: 26267924
[No Abstract] [Full Text] [Related]
14. Recognition and treatment of iron overload.
Brown EB
Adv Intern Med; 1980; 26():159-86. PubMed ID: 7013439
[No Abstract] [Full Text] [Related]
15. Neonatal hemochromatosis: failure of deferoxamine therapy.
Jonas MM; Kaweblum YA; Fojaco R
J Pediatr Gastroenterol Nutr; 1987; 6(6):984-8. PubMed ID: 3681586
[TBL] [Abstract][Full Text] [Related]
16. Treatment of iron overload.
Cohen A; Witzleben C; Schwartz E
Semin Liver Dis; 1984 Aug; 4(3):228-38. PubMed ID: 6091277
[No Abstract] [Full Text] [Related]
17. The pathology of the liver in hemochromatosis.
Powell LW; Kerr JF
Pathobiol Annu; 1975; 5():317-37. PubMed ID: 1196674
[No Abstract] [Full Text] [Related]
18. [Iron metabolism. Current aspects of iron overload].
Williams R
Recenti Prog Med; 1980 Feb; 68(2):97-127. PubMed ID: 6988908
[No Abstract] [Full Text] [Related]
19. Hepatitis C virus infection and liver disease in children with thalassemia.
Locasciulli A; Monguzzi W; Tornotti G; Bianco P; Masera G
Bone Marrow Transplant; 1993; 12 Suppl 1():18-20. PubMed ID: 7690633
[TBL] [Abstract][Full Text] [Related]
20. Management of iron overload with a disposable multi-day delivery system.
Paolo C; Francesco S; Sergio A
Am J Hematol; 1996 Jan; 51(1):95. PubMed ID: 8571948
[No Abstract] [Full Text] [Related]
[Next] [New Search]
